This month’s issue highlights that Centers for Medicare & Medicaid Services (CMS) in the United States has proposed Medicare payment rates for hospital outpatient and Ambulatory Surgical Center (ASC) services for the calendar year 2023. If the proposed rule is finalized without changes, this would mean that scalp cooling treatments billed with the CPT code 0662T will continue to have a payment rate of 1,850.50 USD. The final rule will be issued in early November.

The newsletter also includes information on that Paxman Scalp Cooling is available at 6 of the 10 top U.S. cancer hospitals, orders from locations in eight states in the US, several customers in the UK as well as from France, Schweiz and Singapore, the launch of Paxman’s PSCS system in Japan and that the company’s distributors in Colombia and Singapore received market clearance for Paxman Scalp Cooling from each country’s respective regulatory agency in charge of medical devices.

To read the newsletter and subscribe for upcoming issues, follow this link:

https://bit.ly/paxaug22en

Paxman’s investor newsletter is published monthly as a part of the company’s effort to strengthen its market communication together with the IR communication agency Honeybadger. Every published issue of the newsletter is available on Paxman’s website for investors, www.paxman.se. The company encourages feedback and requests on topics for upcoming issues of the newsletter.

For more information, please contact:
Richard Paxman, CEO
Tel: +44 7968 020641
Email: richard@paxmanscalpcooling.com
www.paxman.se